纤维肌痛与风湿性因素升高与治疗反应不佳有关,但与风湿性关节炎的进展无关. 预期的队列研究
Freddy Liñán Ponce1, Juan Leiva Goicochea1, David Sevilla Rodríguez1
1Servicio de Reumatología, Hospital Víctor Lazarte Echegaray, Trujillo, Peru.
Reumatologia clinica
|October 25, 2024
概括
纤维肌痛 (FM) 与高类风湿因子 (RF) 显示治疗反应较差,但不会增加类风湿关节炎 (RA) 的进展. 这一发现对于了解FM患者的治疗结果至关重要.
科学领域:
- 类风湿病学 类风湿病学
- 临床免疫学临床免疫学
背景情况:
- 纤维肌痛 (FM) 是一种慢性疾病,其特点是普遍存在的疼痛.
- 在 FM 患者中风湿因子 (RF) 水平升高可能表明一个不同的亚组.
- 高射频和FM治疗结果之间的关联需要进一步调查.
研究的目的:
- 评估纤维肌痛患者的治疗反应,这些患者的风湿性因素 (RF) 升高.
- 评估纤维肌痛患者患有高射频的类风湿性关节炎 (RA) 的进展风险.
主要方法:
- 一项前性队列研究包括124名纤维肌痛患者,分为高射频 (>20 U/mL) 和负射频 (0-20 U/mL) 组.
- 患者使用纤维肌痛影响治疗改善得分 (FIQR) 和EULAR/ACR 2010标准对RA在6个月和12个月后的进展进行了评估.
- 用皮尔森的二次测试来分析不同组之间的治疗改善和RA进展率.
主要成果:
- 与负射频组相比,高射频患者在6个月和12个月后的治疗反应率显著降低.
- 高射频和负射频组之间进展为类风湿性关节炎的发生率相似,没有统计学上显著的差异.
- 这表明,在 FM 中高射频与治疗疗效有关,但与疾病转变无关.
结论:
- 纤维肌痛与风湿性因素升高相关,其特点是对治疗的反应减弱.
- 纤维肌痛患者的高射频似乎不是风湿性关节炎发展的预测因素.
- 这些发现强调了考虑RF水平对于个性化的FM管理策略的重要性.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
7
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
7
01:23Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
01:21Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
01:20Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
80
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
80
01:20The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K